Additional partial hepatectomy at the time of portal vein ligation accelerates the regeneration of the future liver remnant.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 06 2021
Historique:
received: 04 08 2020
accepted: 04 05 2021
entrez: 4 6 2021
pubmed: 5 6 2021
medline: 30 11 2021
Statut: epublish

Résumé

Portal vein ligation (PVL) has been adopted to induce hypertrophy of the future liver remnant (FLR) in patients with primarily irresectable liver tumor. However, regeneration of the FLR is not always sufficient to allow curative resection of the portally-deprived tumor-bearing liver lobe. We hypothesize that simultaneous hepatectomy (PHx) and PVL augments regeneration of the FLR and that the effect is related to the extent of the additional resection. Seventy-two Lewis rats were enrolled into 3 groups: 20%PVL + 70%PHx; 70%PVL + 20%PHx; 90%PVL. Animals were observed for 1, 2, 3 and 7 days postoperatively (n = 6/time point). Liver enzymes, caudate liver/body-weight-ratio, BrdU-proliferation-index (PI), proliferating-cell-nuclear-antigen (PCNA)-mRNA-expression level and autophagy-related-proteins were evaluated. Compared with 90% PVL, additional PHx induced significantly more hypertrophy during the observation time, which was confirmed by significantly higher PI and higher level of PCNA-mRNA expression. Similarly, the additional PHx induced more autophagy in the FLR compared with PVL alone. However, both effects were not clearly related to the extent of additional resection. Additional resection augmented liver regeneration and autophagy substantially compared with PVL alone. Therefore, we concluded that autophagy might play a critical role in regulating hepatocyte proliferation and the size of the FLR after simultaneous PVL + PHx.

Identifiants

pubmed: 34083554
doi: 10.1038/s41598-021-90819-x
pii: 10.1038/s41598-021-90819-x
pmc: PMC8175446
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11740

Références

Br J Surg. 2011 Oct;98(10):1463-75
pubmed: 21710481
HPB (Oxford). 2018 Dec;20(12):1109-1118
pubmed: 30057123
Hepatology. 2014 Jul;60(1):290-300
pubmed: 24668739
Autophagy. 2016;12(1):1-222
pubmed: 26799652
J Exp Med. 1920 Apr 30;31(5):609-32
pubmed: 19868417
Hepatology. 1993 Jul;18(1):79-85
pubmed: 8392029
Liver Transpl. 2013 Jul;19(7):762-72
pubmed: 23696274
HPB (Oxford). 2010 Mar;12(2):81-3
pubmed: 20495650
Sci Rep. 2015 Feb 13;5:8455
pubmed: 25678050
Med Sci Monit. 2019 Jul 31;25:5674-5682
pubmed: 31364611
Anal Biochem. 2015 May 15;477:13-20
pubmed: 25747848
Am J Surg. 2003 Mar;185(3):221-9
pubmed: 12620560
Br J Surg. 1999 Jun;86(6):784-8
pubmed: 10383579
Hepatology. 2001 Aug;34(2):267-72
pubmed: 11481611
Sci Rep. 2015 Oct 30;5:15807
pubmed: 26515640
Ann Surg. 2000 Dec;232(6):777-85
pubmed: 11088072
Eur J Gastroenterol Hepatol. 2020 Jul;32(7):769-778
pubmed: 31834053
Dig Liver Dis. 2009 Nov;41(11):798-806
pubmed: 19303376
Eur Surg Res. 2015;54(3-4):148-61
pubmed: 25592812
Surgery. 1990 May;107(5):521-7
pubmed: 2333592
Int J Surg. 2018 Apr;52:74-81
pubmed: 29425829
J Surg Oncol. 2010 Dec 15;102(8):960-7
pubmed: 21165999
Ann Hepatol. 2019 Jan - Feb;18(1):89-100
pubmed: 31113614
J Surg Res. 2011 Dec;171(2):669-74
pubmed: 20605581
Eur Surg Res. 2009;42(3):181-8
pubmed: 19246925
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Med Sci Monit. 2017 Dec 18;23:5986-5993
pubmed: 29249797
PLoS One. 2015 Dec 02;10(12):e0144096
pubmed: 26630386
HPB (Oxford). 2020 Apr;22(4):487-496
pubmed: 31786053
Cell Death Dis. 2019 Jun 20;10(7):489
pubmed: 31222000
Sci Rep. 2017 Dec 22;7(1):18065
pubmed: 29273725
J Hepatol. 2002 Jul;37(1):72-7
pubmed: 12076864
Sci Rep. 2020 Mar 17;10(1):4893
pubmed: 32184404
Eur Surg Res. 2016;57(1-2):125-37
pubmed: 27308828
Oncotarget. 2017 Feb 21;8(8):12637-12648
pubmed: 28061452
Biomed Res Int. 2018 Jul 31;2018:3817057
pubmed: 30151380
Organogenesis. 2019;15(1):24-34
pubmed: 31280650
Surg Oncol. 2017 Sep;26(3):257-267
pubmed: 28807245
Ann Surg. 2012 Nov;256(5):812-7; discussion 817-8
pubmed: 23095626

Auteurs

Chuanfeng Hua (C)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.

Weiwei Wei (W)

Department of Visceral-, Transplant-, Thoracic- and Vascular Surgery, University Clinic Leipzig, Liebigstraße 20, Haus 4, 04103, Leipzig, Germany.

Tianjiao Zhang (T)

Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena, Germany.

Fengming Xu (F)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.

Olaf Dirsch (O)

Institute of Pathology, Klinikum Chemnitz gGmbH, Chemnitz, Germany.

André Homeyer (A)

Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany.

Utz Settmacher (U)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.

Uta Dahmen (U)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany. Uta.Dahmen@med.uni-jena.de.

Articles similaires

C-Reactive Protein Humans Biomarkers Inflammation
Humans Hepatectomy Male Female Retrospective Studies
Animals Dogs Dog Diseases Autophagy Immunohistochemistry
Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae

Classifications MeSH